UCSF

Tagged: big data

Oni-Orisan given the Darrell Abernethy Early Stage Investigator Award

Oni-Orisan was recognized for his contributions to clinical pharmacology.

Michael Douglas

TRANSPERS Program Manager

As program manager for the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), my work focuses on the value of new technologies and how to most effectively and efficiently implement them into health care, with a particular focus on personalized (or precision) medicine...

Kendall Gross, PharmD

Access Extension

I work as a critical care pharmacist practicing in the medical/surgical intensive care units at UCSF Medical Center. My interests in improvement work and high value care led me to a role in the Medication Outcomes Center where I conduct research and quality improvement work. My specific research...

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Finding better ways to reduce serious drug side effects

Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about 40,000 deaths yearly in the United States may be attributable to the side...

Koda-Kimble Seed Award recipients explore ‘blue-sky’ projects

Recipients of the UCSF School of Pharmacy 2017 Mary Anne Koda-Kimble Seed Award for Innovation will explore ideas ranging from possible new ways to treat obesity to new ways of accessing antibiotic-producing microbes found in soil.

Abate honored by White House with Presidential Early Career Award

UCSF School of Pharmacy faculty member Adam Abate, PhD, has been named a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the U.S. government on science and engineering professionals in the early stages of their independent research...

Kathryn Phillips, PhD

Professor

My work focuses on the translation of new technologies into improved patient outcomes, particularly the translation of personalized/precision medicine—targeting health care interventions to patients based on their genetics—into clinical care and health policy.